Epidemiology and prognostic factors of systemic candidosis in intensive care unit;Épidémiologie et facteurs de risque des candidoses systémiques en réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 20, Issue 4, 2001, Pages 394-399

  Gauzit, R ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Candida spp.; Epidemiology; Intensive care unit; Mortality; Prognostic factors; Risk factors; Systemic candidosis

Indexed keywords

CANDIDIASIS; HOSPITAL PERSONNEL; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MORBIDITY; MORTALITY; PROGNOSIS; REVIEW; RISK FACTOR; STRAIN DIFFERENCE; WORKLOAD; CROSS INFECTION; EUROPE; FRANCE; MICROBIOLOGY; PATHOLOGY; UNITED STATES;

CANDIDIASIS; CROSS INFECTION; EUROPE; FRANCE; HUMANS; INTENSIVE CARE UNITS; PROGNOSIS; RISK FACTORS; UNITED STATES;

EID: 0035023883     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(01)00370-7     Document Type: Article

References (31)

1. When to start antifungal therapy in the non-neutropenic critically ill?
2. Secular trends in the epidemiology of nosocomial fungal infections in the United States,-1990 National Nosocomial Infections Surveillance System
3. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths
4. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units
5. Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy
6. Epidemiology of invasive mycosis in ICU patients: A prospective multicenter study in 435 non-neutropenic patients
7. Attributable mortality and additional workload for ICU patients with systemic candidiasis: A matched cohort study
8. Predominant pathogens in hospital infections
9. National surveillance of nosocomial infection due to Candida albicans: Frequency for occurrence and antifungal susceptibility in the SCOPE Program
10. Nosocomial bloodstream infections in United States Hospitals: A three-year analysis
11. Nosocomial infection surveillance in the United States: Historical perspective
12. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
13. Nosocomial infections in an oncology intensive care unit
14. The epidemiology of hematogenous candidiasis caused by different Candida species
15. Emergence of Candida parapsilosis as the predominent species causing candidemia in children
16. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in the United States, Canada, and South America for the SENTRY Program
17. Candidemia in intensive care unit patients: Risk factors for mortality
18. Therapeutic approaches in patients with candidemia: Evaluation in a multicenter, prospective, observational study
19. Evidence for nosocomial transmission of Candida albicans obtained by Ca3 fingerprinting
20. Molecular typing of Candida albicans strains isolated from nosocomial candidemia
21. Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3
22. An experimental model for study of Candida survival and transmission in human volunteers
23. Investigation on the sequence of colonization and candidemia in non-neutropenic patients
24. The role of Candida in intraperitoneal infections
25. Are we making progress in antifungal therapy?
26. Candida colonization and subsequent infections in critically ill surgical patients
27. Intravascular catheter exchange and duration of candidemia
28. Predictors of adverse outcome in patients with candidemia
29. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections
30. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care
31. Hospital-acquired candidemia: The attributable mortality and excess length of stay